Which members of Congress traded Vertex Pharmaceuticals VRTX recently?

The latest reported trades: Rep. David Taylor, full sale on 08/26 (reported 09/05), Sen. Tommy Tuberville, full sale on 24/05/03 (reported 08/05), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. David Taylor, full sale on 01/29 (reported 02/02) and Rep. Julia Letlow, purchase on 24/10/23 (reported 01/13).

Stocks

Vertex Pharmaceuticals VRTX

Health care sectorNasdaq

What to see in Vertex Pharmaceuticals now

Is Wall Street adding or cutting?+57

1,754 13F filers hold it · +57 against the quarter before · shares held +1.9%

Holdings of 06/30

Are members of Congress buying or selling?2

2 members of Congress traded it in 90 days · 1 purchases · 1 sales

Reported 09/05

How much more do Koreans hold through ETFs?$205.7M

Koreans hold $205.7M more through 11 ETFs

Holdings of 05/31

Company

Exchange: Nasdaq
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Boston, Massachusetts
Fiscal year end: 12/31
Next earnings: 11/02, estimated

1,754 13F filers hold it · +57 against the quarter before · shares held +1.9%Holdings of 06/30

Funds

13F filers: 1,754 · +57 since the quarter before · 06/30 holdings

Famous funds that held Vertex Pharmaceuticals in their latest 13F report.

Fund	Shares	Value	Share of the portfolio	Since the quarter before
National Pension ServiceVertex Pharmaceuticals VRTX · 06/30 holdings	539,530 sh	$268M	0.2%	Added +1.4%
Korea InvestmentVertex Pharmaceuticals VRTX · 06/30 holdings	213,312 sh	$106M	0.2%	Added +6.0%
Mirae Asset Global InvestmentsVertex Pharmaceuticals VRTX · 06/30 holdings	210,209 sh	$104.4M	0.2%	Added +11.8%
Mirae Asset Global ETFS HoldingsVertex Pharmaceuticals VRTX · 06/30 holdings	150,692 sh	$74.7M	0.1%	No quarter before
Bridgewater AssociatesVertex Pharmaceuticals VRTX · 06/30 holdings	10,865 sh	$5.4M	<0.1%	Trimmed −18.7%

All tracked funds

5% stakes

	Holder			Kind
05/14	Capital World Investors05/14	10.1%25,695,015 sh	−1.1pp	13G passiveAmendment
05/14	Capital Research Global Investors05/14	8.3%21,139,169 sh	+1.5pp	13G passiveAmendment
04/30	Vanguard Capital Management04/30	7.49%19,036,076 sh	First report	13G passive
02/12	Capital Research Global Investors02/12	6.8%17,319,044 sh	+1.1pp	13G passiveAmendment
25/05/13	Capital Research Global Investors25/05/13	5.7%14,536,344 sh	First report	13G passive

All 5% stake reports on Vertex Pharmaceuticals

26-week trading

Members of Congress reported 3 trades in Vertex Pharmaceuticals VRTX in the past 90 days (1 purchase, 2 sales).

Common questions

Which members of Congress traded Vertex Pharmaceuticals VRTX recently?: The latest reported trades: Rep. David Taylor, full sale on 08/26 (reported 09/05), Sen. Tommy Tuberville, full sale on 24/05/03 (reported 08/05), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. David Taylor, full sale on 01/29 (reported 02/02) and Rep. Julia Letlow, purchase on 24/10/23 (reported 01/13).